Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 39, Pages 19646-19651
Publisher
Proceedings of the National Academy of Sciences
Online
2019-09-10
DOI
10.1073/pnas.1907946116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The NMR solution structure of Mycobacterium tuberculosis F-ATP synthase subunit ε provides new insight into energy coupling inside the rotary engine
- (2018) Shin Joon et al. FEBS Journal
- Ionophoric effects of the antitubercular drug bedaquiline
- (2018) Kiel Hards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds
- (2018) Mattia Zampieri et al. Science Translational Medicine
- Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
- (2017) Emanuele Pontali et al. EUROPEAN RESPIRATORY JOURNAL
- Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform
- (2017) A. Theron et al. PLoS One
- Nontargeted Metabolomics Reveals the Multilevel Response to Antibiotic Perturbations
- (2017) Mattia Zampieri et al. Cell Reports
- Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
- (2016) Dirk A. Lamprecht et al. Nature Communications
- Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
- (2016) Eliza J. R. Peterson et al. Nature Microbiology
- Bactericidal mode of action of bedaquiline
- (2015) K. Hards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic discovery of drug interaction mechanisms
- (2015) G. Chevereau et al. Molecular Systems Biology
- Antibiotic efficacy is linked to bacterial cellular respiration
- (2015) Michael A. Lobritz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage
- (2015) Peter Belenky et al. Cell Reports
- Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm : Figure 1.
- (2015) Sumit Chakraborty et al. Cold Spring Harbor Perspectives in Medicine
- Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis Machinery
- (2014) Hongbaek Cho et al. CELL
- Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis
- (2014) Sherry Mowbray et al. MOLECULES
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis
- (2014) Madhumitha Nandakumar et al. Nature Communications
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- In VitroCombination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
- (2012) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase Inhibitors
- (2012) Johan Gising et al. JOURNAL OF MEDICINAL CHEMISTRY
- Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis
- (2012) S. Chakraborty et al. SCIENCE
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability
- (2009) M. Gengenbacher et al. MICROBIOLOGY-SGM
- Synergistic drug combinations tend to improve therapeutically relevant selectivity
- (2009) Joseph Lehár et al. NATURE BIOTECHNOLOGY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is resistance useless? Multidrug resistance and collateral sensitivity
- (2009) Matthew D. Hall et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal Structures of Mammalian Glutamine Synthetases Illustrate Substrate-Induced Conformational Changes and Provide Opportunities for Drug and Herbicide Design
- (2007) Wojciech W. Krajewski et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation